# Autoliv Inc: Form 10-Q for the period ended Sep 30, 2025

- Company: [Autoliv Inc](/companies/alv.md) (CIK 1034670)
- Form: 10-Q
- Filed: 2025-10-17
- Accepted by EDGAR: Oct 17, 2025, 09:27 ET
- Period: 2025-09-30
- Accession: 0001193125-25-242063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034670/000119312525242063/alv-20250930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034670/000119312525242063/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $2.71bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2025-01-01 to 2025-09-30 | $8.00bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-07-01 to 2025-09-30 | $2.18bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2025-01-01 to 2025-09-30 | $6.50bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2025-07-01 to 2025-09-30 | $522.0m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2025-01-01 to 2025-09-30 | $1.50bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2025-07-01 to 2025-09-30 | $117.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2025-01-01 to 2025-09-30 | $319.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2025-07-01 to 2025-09-30 | $137.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2025-01-01 to 2025-09-30 | $427.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-07-01 to 2025-09-30 | $267.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2025-01-01 to 2025-09-30 | $769.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-07-01 to 2025-09-30 | $25.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2025-01-01 to 2025-09-30 | $77.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $65.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $183.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $175.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | $509.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $6.59 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $6.61 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 76,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 77,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $613.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2025-07-01 to 2025-09-30 | $106.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $323.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2025-01-01 to 2025-09-30 | $173.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2025-09-30 | $225.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-09-30 | $3.95bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-09-30 | $8.46bn | us-gaap:Assets |
| Current liabilities | at 2025-09-30 | $4.14bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2025-09-30 | $1.37bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2025-09-30 | $654.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-09-30 | $2.55bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 55,761 characters.

*The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and accompanying Notes thereto included elsewhere herein and with our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the United States Securities and Exchange Commission (the “SEC”) on February 20, 2025. Unless otherwise noted, all dollar amounts are in millions.*

Autoliv, Inc. (“Autoliv” or the “Company”) is a Delaware corporation with its principal executive offices in Stockholm, Sweden. The Company functions as a holding corporation and owns two principal operating subsidiaries, Autoliv AB and Autoliv ASP, Inc.

Through its operating subsidiaries, Autoliv is a supplier of automotive safety systems with a broad range of product offerings, including modules and components for passenger and driver airbags, side airbags, curtain airbags, seatbelts, steering wheels, and pedestrian protection systems.

Autoliv’s filings with the SEC, including this Quarterly Report on Form 10-Q, annual reports on Form 10-K, current reports on Form 8-K, proxy statements, and all of our other reports and statements, and amendments thereto, are available free of charge on our corporate website at www.autoliv.com as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC (generally the same day as the filing).

The primary exchange market for Autoliv’s securities is the New York Stock Exchange ("NYSE") where Autoliv’s common stock trades under the symbol “ALV”. Autoliv’s Swedish Depositary Receipts ("SDRs") are traded on Nasdaq Stockholm’s list for large market cap companies under the symbol “ALIV SDB”. Options in SDRs trade on Nasdaq Stockholm under the name “Autoliv SDB”. Options in Autoliv shares are traded on Nasdaq OMX PHLX and on NYSE Amex Options under the symbol “ALV”.

Autoliv’s fiscal year ends on December 31.

### Non-U.S. GAAP financial measures

Some of the following discussions refer to non-U.S. GAAP financial measures: see reconciliations for “Organic sales,” “Free operating cash flow,” “Cash conversion,” “Net debt,” “Leverage ratio,” “Adjusted net income,” “Adjusted operating income,” “Adjusted operating margin,” “Adjusted earnings per share, diluted,” “Adjusted return on capital employed,” and “Adjusted return on total equity” provided below. Management believes that these non-U.S. GAAP financial measures provide supplemental information to investors regarding the performance of the Company’s business and assist investors in analyzing trends in the Company's business. Additional descriptions regarding management’s use of these financial measures are included below. Investors should consider these non-U.S. GAAP financial measures in addition to, rather than as substitutes for, financial reporting measures prepared in accordance with U.S. GAAP. These historical non-U.S. GAAP financial measures have been identified as applicable in each section of this report with a tabular presentation reconciling them to the most directly comparable U.S. GAAP financial measures. It should be noted that these measures, as defined, may not be comparable to similarly titled measures used by other companies.

### EXECUTIVE OVERVIEW

We are pleased to, once again, report a record breaking quarter. This quarter is the best third quarter so far, for sales, operating income and EPS. The performance was driven by better than expected sales, especially in Americas and Europe, and successful actions to reduce costs and achieve tariff compensation. We are pleased that we had a solid outperformance with the domestic Chinese OEMs. The ramp-up of certain models started slower than expected, but improved gradually during the quarter. We expect increased outperformance in China in the fourth quarter. Driven by increased penetration of automotive safety, our high growth in India continued, accounting for around one third of our global organic growth in the third quarter.

We invest for continued success in China. We started building a second R&D Center in China to support our growing business with Chinese OEMs both in China and globally. In addition, in October we signed a strategic agreement with CATARC, the leading research institution setting standards in China’s automotive sector, to jointly advance automotive safety standards and innovation. Furthermore, we recently announced our plans to form a joint venture with HSAE, a leading Chinese automotive electronics developer, to develop and manufacture advanced safety electronics to increase vertical integration of our product portfolio.

We recovered around 75% of tariff costs in the third quarter, and expect to recover most of what remains in the fourth quarter. We continue to closely monitor the situation, and remain adaptive and agile.

Our focus on operational efficiency, commercial excellence and our cost reduction programs continue to yield results. In the quarter, sales grew organically by 4% (Non-U.S. GAAP measure, see reconciliation table below), gross profit by 14%, operating income by 18% and EPS by 31%. Supported by strong balance sheet control, operating cash flow increased by 46%, and with a lower capex, net, free cash flow (Non-U.S. GAAP measure, see reconciliation table below) improved substantially. As a result, we kept our leverage ratio (Non-U.S. GAAP measure, see reconciliation table below) at 1.3x, despite increasing the dividend by 21% and repurchasing shares for $100 million in the quarter.

We remain confident in achieving our full year guidance of an adjusted operating margin (Non-U.S. GAAP measure) of around 10-10.5%, currently expecting to come in at the midpoint of the range.

### Financial highlights in the three months period ended September 30, 2025

*Change figures below compare to the same period of the previous year, except when stated otherwise.*

**$2,706 million** net sales

**5.9%** net sales increase

**3.9%** organic sales growth (Non-U.S. GAAP measure, see reconciliation table below)

**9.9%** operating margin

**10.0%** adjusted operating margin (Non-U.S. GAAP measure, see reconciliation table below)

**$2.28** diluted EPS, 31% increase

**$2.32** adjusted diluted EPS (Non-U.S. GAAP measure, see reconciliation table below), 26% increase

### Key business developments in the three months period ended September 30, 2025

*Change figures below compare to the same period of the previous year, except when stated otherwise.*

- **Net sales increased organically** (Non-U.S. GAAP measure, see reconciliation table below) by 3.9%, which was 0.7pp lower than the global LVP increase of 4.6% (S&P Global Oct 2025). Regional and customer LVP mix is estimated to have negatively impacted sales by about 1pp, while tariff compensations added around 0.5pp. We outperformed in Asia, excl. China and Americas and underperformed in China and Europe. Our organic sales growth (Non-U.S. GAAP measure) in China to Chinese OEMs was about 8pp higher than COEM LVP growth. We expect that our record number of new launches will continue to support our sales performance in China in the fourth quarter.
- **Profitability improved significantly**, mainly due to organic sales growth, successful execution of cost reductions, and positive effects from supplier settlement and compensation. We estimate that the negative impact from U.S. tariffs was around 20bps on operating margin, as we managed to pass on most of the tariff costs to our customers. Operating income increased by 18% to $267 million and adjusted operating income (Non-U.S. GAAP measure, see reconciliation table below) increased by 14% to $271 million. Operating margin was 9.9% and adjusted operating margin (Non-U.S. GAAP measure, see reconciliation table below) was 10.0%. ROCE was 25.1% and adjusted ROCE (Non-U.S. GAAP measure, see reconciliation table below) was 25.5%.
- **Operating cash flow** increased by 46%, reflecting improved profit and working capital. Capital expenditure, net, was significantly reduced, and free operating cash flow (Non-U.S. GAAP measure, see reconciliation table below) increased substantially. The leverage ratio (Non-U.S. GAAP measure, see reconciliation table below) of 1.3x is below our target limit of 1.5x. In the quarter, a dividend of $0.85 per share (21% increase from the second quarter of 2025) was paid and 0.84 million shares were repurchased and retired.

### Business and market condition update

### Supply Chain

In the third quarter of 2025, global LVP increased by 4.6% year-over-year (according to S&P Global Oct 2025). Call-off volatility improved slightly compared to a year earlier, although it remains higher than pre-pandemic levels. Low customer demand visibility and changes to customer call-offs with short notice, although they improved, continued to have some negative impact on our production efficiency and profitability. We expect call-off volatility for the full year 2025 on average to be slightly lower than it was in 2024 but still remain higher than pre-pandemic levels. However, the continued uncertainty regarding future changes in tariffs and trade restrictions may lead to a more negative call-off volatility environment.

### Inflation

In the third quarter, cost pressure from labor and other items impacted our profitability negatively, although to a lesser degree than in the third quarter of 2024. Most of the inflationary cost pressure was offset by price increases and other customer compensations in the quarter. Raw material price changes did not have a meaningful impact on our profitability during the quarter. The continued uncertainty regarding the effects of tariffs and trade restrictions may lead to a more adverse inflation environment. We continue to execute on productivity and cost reduction initiatives to offset these cost pressures.

### Geopolitical risks and tariffs

The effects from the new tariffs imposed in the first nine months of the year did not have a material impact on our profitability in the third quarter, as we achieved customer compensations for most tariff costs. It is our ambition and expectation that we will continue to pass on tariff costs to our customers, although there is significant uncertainty. We recovered around 75% of the tariffs in the third quarter, and we expect to recover most of what remains later in the year. The impact of the tariffs not yet recovered on our operating income was around $5 million negative in the quarter. Including the dilutive effect of tariffs recovered, operating margin was negatively impacted by around 20bps. For the full year 2025, we expect the tariff dilution on our operating margin to be around 20 bps. Geopolitical uncertainties will continue to create a challenging operating environment. Any new, increased or changed tariffs or other related trade restrictions imposed during the remainder of 2025 may impact our operations and contribute to the uncertainty of industry expectations. We continue to closely monitor the tariff policy environment and are prepared to remain agile in responding to any such developments.

### RESULTS OF OPERATIONS

### Overview

The following table shows some of the key ratios management uses internally to analyze the Company's current and future financial performance and core operations as well as to identify trends in the Company’s financial conditions and results of operations. The Company has provided this information to investors to assist in meaningful comparisons of past and present operating results and to assist in highlighting the results of ongoing core operations. These ratios are more fully explained below and should be read in conjunction with the consolidated financial statements in the Company's Annual Report on Form 10-K and the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

The Company's management uses the Return on capital employed (ROCE) and Return on total equity (ROE) measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company’s business. As used by the Company, ROCE is annualized operating income and income from equity method investments relative to average capital employed. The Company believes ROCE is a useful indicator of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company’s capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. The Company’s management believes that ROE is a useful indicator of how well management creates value for its shareholders through its operating activities and its capital management.

### KEY RATIOS

### (Dollars in millions, except per share data)

|  | Three Months Ended or As of September 30, 2025 | 2024 | Nine Months Ended or As of September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| Receivables outstanding relative to sales, %1) | 21.8% | 21.5% | - | - |
| Inventory outstanding relative to sales, %2) | 9.6% | 9.8% | - | - |
| Payables outstanding relative to sales, %3) | 17.5% | 18.4% | - | - |
| Gross margin, %4) | 19.3% | 18.0% | 18.8% | 17.7% |
| Operating margin, %5) | 9.9% | 8.9% | 9.6% | 8.1% |
| Capital employed6) | 4,331 | 4,085 | - | - |
| Net debt7) | 1,772 | 1,787 | - | - |
| Return on total equity, %8) | 27.9% | 24.1% | 28.1% | 22.4% |
| Return on capital employed, %9) | 25.1% | 22.9% | 24.9% | 21.2% |
| Headcount at period-end10) | 65,200 | 67,200 | - | - |

1\) Outstanding receivables relative to annualized quarterly sales.

2\) Outstanding inventory relative to annualized quarterly sales.

3\) Outstanding payables relative to annualized quarterly sales.

4\) Gross profit relative to sales.

5\) Operating income relative to sales.

6\) Total equity and net debt.

7\) Net debt adjusted for pension liabilities in relation to EBITDA. See tabular presentation reconciling this non-U.S. GAAP measure to U.S. GAAP below.

8\) Net income relative to average total equity.

9\) Operating income and income from equity method investments, relative to average capital employed.

10\) Employees plus temporary, hourly personnel.

### three months period ended September 30, 2025 COMPARED WITH three months period ended September 30, 2024

### Consolidated Sales Development

#### (dollars in millions)

|  | Three Months Ended September 30, 2025 | 2024 | Reported change | Components of change in net sales Currency effects 1) | Organic 3) |
| --- | ---: | ---: | ---: | ---: | ---: |
| Airbags, Steering Wheels and Other2) | $1,830 | $1,736 | 5.4% | 1.8% | 3.6% |
| Seatbelt products and Other2) | 875 | 819 | 6.9% | 2.4% | 4.5% |
| **Total** | **$2,706** | **$2,555** | **5.9%** | **2.0%** | **3.9%** |
| Americas | $897 | $851 | 5.3% | 0.6% | 4.7% |
| Europe | 745 | 700 | 6.4% | 6.3% | 0.1% |
| China | 526 | 495 | 6.3% | 0.1% | 6.2% |
| Asia excl. China | 538 | 508 | 5.8% | 0.3% | 5.5% |
| **Total** | **$2,706** | **$2,555** | **5.9%** | **2.0%** | **3.9%** |

1\) Effects from currency translations.

2\) Including Corporate sales.

3\) Non-U.S. GAAP measure.

### Sales by product - Airbags, Steering Wheels and Other

Sales for Airbags, Steering Wheels and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 3.6% in the quarter. The largest contributors to the increase was inflatable curtains, side airbags, driver airbags and center airbags, followed by smaller increases for passenger airbags and knee airbags. This was partly offset by a decline for steering wheels.

### Sales by product - Seatbelts and Other

Sales for Seatbelt Products and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 4.5% in the quarter. Sales increased organically in all regions, led by strong growth in Europe and Americas followed by China and Asia excluding China.

### Sales by region

Our global organic sales (Non-U.S. GAAP measure, see reconciliation table above) increased by 3.9% compared to the global LVP increase of 4.6% (according to S&P Global, October 2025). The relative performance was positively impacted by product launches and tariff compensations. This was more than offset by negative effects from the regional and model LVP mix development, which we estimate contributed to about 1pp underperformance. This was particularly accentuated in China. Our organic sales growth (Non-U.S. GAAP measure, see reconciliation table above) underperformed LVP growth by 3.5pp in China and by 1.2pp in Europe, while we outperformed by 4.2pp in Asia, excl. China and by 0.5pp in Americas.

LVP growth in China was driven by domestic OEMs with typically lower safety content. LVP for global OEMs was unchanged while it increased by 15% for domestic OEMs. Autoliv's sales growth with domestic OEMs grew by 23% while our sales with global OEMs decreased by 5%. Our sales performance relative to LVP in China in the quarter is a significant improvement over recent quarters.

We expect that our strong order intake with domestic OEMs and a record high number of new launches will further improve our relative sales performance in China in the fourth quarter of 2025.

**Third quarter of 2025 organic growth**1)

|  | Americas | Europe | China | Asia excl. China | Global |
| --- | --- | --- | --- | --- | --- |
| Autoliv | 4.7 % | 0.1% | 6.2% | 5.5% | 3.9 % |
| Main growth drivers | Stellantis, Toyota, Ford | VW, Stellantis, BMW | Chery, Great Wall, GM | Suzuki, Hyundai, Toyota | Stellantis, Suzuki, Toyota |
| Main decline drivers | GM, VW, Mazda | JLR, Hyundai, EV OEM | EV OEM, Mercedes, EV COEM | Mitsubishi, Nissan, Honda | Mercedes, EV OEM, GM |

1\) Non-U.S. GAAP measure.

### Light Vehicle Production Development

#### Change third quarter of 2025 versus third quarter of 2024

|  | Americas | Europe | China | Asia excl. China | Global |
| --- | ---: | ---: | ---: | ---: | ---: |
| LVP1) | 4.2 % | 1.3 % | 9.7 % | 1.3 % | 4.6 % |

24

1\) Source: S&P Global, October 2025.

### Earnings

*(Dollars in millions, except per share data)*

|  | Three Months Ended September 30, 2025 | 2024 | Change |
| --- | ---: | ---: | ---: |
| Net Sales | $2,706 | $2,555 | 5.9% |
| Gross profit | 522 | 459 | 13.7% |
| % of sales | 19.3% | 18.0% | 1.3 pp |
| S, G&A | (137) | (129) | 6.2% |
| % of sales | (5.1)% | (5.0)% | (0.0 )pp |
| R, D&E, net | (117) | (96) | 23% |
| % of sales | (4.3)% | (3.7)% | (0.6 )pp |
| Other income (expense), net | (1) | (9) | (91)% |
| Operating income | 267 | 226 | 18.1% |
| % of sales | 9.9% | 8.9% | 1.0 pp |
| Adjusted operating income1) | 271 | 237 | 14.2% |
| % of sales | 10.0% | 9.3% | 0.7 pp |
| Financial and non-operating items, net | (27) | (29) | (7.5)% |
| Income before taxes | 240 | 197 | 21.9% |
| Income taxes | (65) | (58) | 11% |
| Tax rate | 26.9% | 29.6% | (2.6 )pp |
| Net income | 175 | 139 | 26.4% |
| Earnings per share, diluted2) | 2.28 | 1.74 | 31% |
| Adjusted earnings per share, diluted1,2) | 2.32 | 1.84 | 26% |

1\) Non-U.S. GAAP measure, excluding effects from capacity alignments and antitrust related matters.

2\) Net of treasury shares.

### Third quarter of 2025 financial development

**Gross profit** increased by $63 million, and gross margin increased by 1.3pp compared to the prior year. The drivers behind the gross profit improvement were mainly positive effects from higher sales and improved operational efficiency with lower costs for labor and waste and scrap. The gross profit improvement was also due to a third quarter of 2024 $14 million cost related to a supplier settlement and a third quarter of 2025 $15 million (unrelated) supplier compensation (of which around $13 million impacted gross profit) as well as lower material costs. This was partly offset by negative effects from recalls and warranty, depreciation and un-recovered tariff costs.

**S,G&A** costs increased by $8 million compared to the prior year, mainly due to higher costs for personnel. S,G&A costs in relation to sales increased from 5.0% to 5.1%.

**R,D&E, net** costs increased by $22 million compared to the prior year, mainly due to lower engineering income. R,D&E, net, in relation to sales increased from 3.7% to 4.3%.

**Other income (expense), net** was negative $1 million, compared to negative $9 million in the same period last year. The difference compared to last year is almost entirely due to lower restructuring costs.

**Operating income** increased by $41 million compared to the prior year, due to the higher gross profit and improvement in Other income (expense), net, partly offset by the higher costs for R,D&E, net, and S,G&A, as outlined above.

**Adjusted operating income** (Non-U.S. GAAP measure, see reconciliation table below) increased by $34 million compared to the prior year, due to the higher gross profit, partly offset by the higher costs for R,D&E, net, and S,G&A, as outlined above.

**Financial and non-operating items, net** was negative $27 million compared to negative $29 million a year earlier. The improvement comes from $2 million in lower interest expense.

**Income before taxes** increased by $43 million compared to the prior year, mainly due to the higher operating income.

**Tax rate** decreased to 26.9% compared to 29.6% the prior year. Discrete tax items, net, had a favorable impact of 1.3pp in the third quarter of 2025, while discrete tax items, net had a favorable impact of 1.2pp in the corresponding quarter last year.

**Earnings per share, diluted** increased by $0.54 compared to the prior year. The main drivers were $0.36 from higher operating income, $0.09 from taxes, $0.08 from lower number of outstanding shares, diluted, and $0.02 from financial items.

### nine months period ended September 30, 2025 compared with nine months period ended September 30, 2024

### Consolidated Sales Development

#### (dollars in millions)

|  | Nine Months Ended September 30, 2025 2024 | Reported change | Components of change in net sales Currency effects 1) Organic 3) |
| --- | ---: | ---: | ---: |
| Airbags, Steering Wheels and Other2) | $5,395 $5,264 | 2.5% | (0.3)% 2.8% |
| Seatbelt products and Other2) | 2,603 2,511 | 3.7% | (0.2)% 3.9% |
| **Total** | **$7,998** **$7,774** | **2.9%** | **(0.3)%** **3.1%** |
|  | **Nine Months Ended September 30,** |  | **Components of change in net sales** |
|  | **2025** **2024** | **Reported change** | **Currency effects 1)** Organic 3) |
| Americas | $2,639 $2,637 | 0.1% | (3.3)% 3.4% |
| Europe | 2,337 2,231 | 4.7% | 2.9% 1.8% |
| China | 1,450 1,423 | 1.9% | (0.3)% 2.2% |
| Asia excl. China | 1,572 1,483 | 6.0% | 0.3% 5.7% |
| **Total** | **$7,998** **$7,774** | **2.9%** | **(0.3)%** **3.1%** |

1\) Effects from currency translations.

2\) Including Corporate sales.

3\) Non-U.S. GAAP measure.

### Sales by product - Airbags, Steering Wheels and Other

Sales for Airbags, Steering Wheels and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 2.8% in the period. The largest contributor to the increase was inflatable curtains and side airbags, followed by center airbags, steering wheels and driver airbags. This was partly offset by declines for knee airbags while sales of passenger airbags were close to unchanged.

### Sales by product - Seatbelts and Other

Sales for Seatbelt Products and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 3.9% in the period. Sales growth was mainly driven by Americas and Asia excluding China followed by Europe and China.

### Sales by region

Our global organic sales (Non-U.S. GAAP measure, see reconciliation table above) increased by 3.1% compared to the global LVP increase of 3.9% (according to S&P Global, October 2025). The relative performance was positively impacted by product launches and tariff compensations. This was more than offset by negative effects from the regional and model LVP mix development, which we estimate contributed to about 3pp underperformance. This was particularly accentuated in China. Our organic sales growth (Non-U.S. GAAP measure, see reconciliation table above) outperformed LVP growth by 3.5pp in Americas, by 3.4pp in Europe and by 3.0pp in Asia excluding China, while we underperformed by 9.3pp in China.

LVP growth in China in the first nine months was driven by domestic OEMs with typically lower safety content. LVP for global OEMs declined by 2.3% while it increased by 20% for domestic OEMs. Autoliv's sales to domestic OEMs increased by 16% in the first nine months of 2025, while it decreased by 5.7% to global OEMs in China. We expect that our strong order intake with domestic OEMs and a record number of new launches will improve Autoliv's sales performance in China in the fourth quarter of 2025.

**First nine months 2025 organic growth**1)

|  | Americas | Europe | China | Asia excl. China | Global |
| --- | --- | --- | --- | --- | --- |
| Autoliv | 3.4 % | 1.8% | 2.2 % | 5.7% | 3.1% |
| Main growth drivers | Toyota, Stellantis, Honda | VW, Stellantis, BMW | Chery, Great Wall, GM | Suzuki, Toyota, Subaru | Toyota, Stellantis, Suzuki |
| Main decline drivers | EV OEM, Hyundai, GM | EV OEM, Hyundai, JLR | EV OEM, Mercedes, Lixiang | Mitsubishi, Honda, GM | EV OEM, Mercedes, Hyundai |

26

1\) Non-U.S. GAAP measure.

### Light Vehicle Production Development

#### Change first nine months of 2025 versus first nine months of 2024

|  | Americas | Europe | China | Asia excl. China | Global |
| --- | ---: | ---: | ---: | ---: | ---: |
| LVP1) | (0.1)% | (1.6)% | 11.5 % | 2.7 % | 3.9 % |

1\) Source: S&P Global, October 2025.

### Earnings

*(Dollars in millions, except per share data)*

|  | Nine Months Ended September 30, 2025 | 2024 | Change |
| --- | ---: | ---: | ---: |
| Net Sales | $7,998 | $7,774 | 2.9% |
| Gross profit | 1,502 | 1,377 | 9.1% |
| % of sales | 18.8% | 17.7% | 1.1 pp |
| S, G&A | (427) | (399) | 7.0% |
| % of sales | (5.3)% | (5.1)% | (0.2 )pp |
| R, D&E, net | (319) | (325) | (1.6)% |
| % of sales | (4.0)% | (4.2)% | 0.2 pp |
| Other income (expense), net | 13 | (27) | (148)% |
| Operating income | 769 | 626 | 23% |
| % of sales | 9.6% | 8.1% | 1.6 pp |
| Adjusted operating income1) | 777 | 657 | 18% |
| % of sales | 9.7% | 8.5% | 1.3 pp |
| Financial and non-operating items, net | (76) | (73) | 4% |
| Income before taxes | 693 | 554 | 25% |
| Income taxes | (183) | (149) | 23% |
| Tax rate | 26.4% | 27.0% | (0.6 )pp |
| Net income | 510 | 404 | 26% |
| Earnings per share, diluted2) | 6.59 | 4.98 | 32% |
| Adjusted earnings per share, diluted1,2) | 6.67 | 5.30 | 26% |

1\) Non-U.S. GAAP measure, excluding effects from capacity alignments and antitrust related matters.

2\) Net of treasury shares.

### First nine months 2025 financial development

**Gross profit** increased by $125 million, and gross margin increased by 1.1pp compared to the prior year. The drivers behind the gross profit improvement were mainly improved operational efficiency with lower costs for labor, logistics, premium freight and waste and scrap. We also had positive effects from the organic sales growth and lower material costs partly offset by negative effects from recall and warranty costs and un-recovered tariffs.

**S,G&A** costs increased by $28 million compared to the prior year, mainly due to increased personnel costs and credit loss reserves following generally higher default risk rate for the automotive industry. This was partly offset by lower costs for professional services. S,G&A costs in relation to sales increased from 5.1% to 5.3%.

**R,D&E, net** costs decreased by $5 million compared to the prior year, mainly due to $7 million from positive foreign currency translation effects and $6 million from lower professional service costs partly offset by $8 million in lower engineering income. R,D&E, net, in relation to sales decreased from 4.2% to 4.0%.

**Other income (expense), net** was positive $13 million, compared to negative $27 million in the same period last year. The improvement compared to last year is due to lower restructuring costs and the recycled accumulated currency translation differences related to the divestment of our idled operations in Russia in Q1 2025.

**Operating income** increased by $143 million compared to the prior year, due to the higher gross profit, lower costs for R,D&E, net, and the improvement in Other income (expense), partly offset by higher costs for S,G&A, as outlined above.

**Adjusted operating income** (Non-U.S. GAAP measure, see reconciliation table below) increased by $120 million compared to the prior year, due to the higher gross profit, lower costs for R,D&E, net, and the improvement in Other income (expense), partly offset by higher costs for S,G&A, as outlined above.

**Financial and non-operating items, net**, was negative $76 million compared to negative $73 million a year earlier. The increase was mainly due to lower interest income and higher non-operating items partly offset by lower interest expense.

**Income before taxes** increased by $140 million compared to the prior year, mainly due to the higher operating income.

**Tax rate** was 26.4% compared to 27.0% in the prior year. Discrete tax items, net, had a favorable impact of 1.8pp in the first nine months of 2025 compared to 2.8pp favorable impact in the same period last year.

**Earnings per share, diluted** increased by $1.61 compared to the prior year. The main drivers were $1.28 from higher operating income and $0.29 from lower number of outstanding shares, diluted, and $0.06 from taxes partly offset by $0.02 from financial items.

### LIQUIDITY AND CAPITAL RESOURCES

The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on its financial position, results of operations or cash flows. The Company’s future contractual obligations have not changed materially from the amounts reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 20, 2025.

### Third quarter of 2025 development

**Changes in operating working capital** impacted operating cash flow by $53 million negative compared to an impact of $68 million negative in the prior year. The working capital increase in the quarter of $53 million was mainly a result of $78 million in negative effects from higher inventories impacted by higher sales and $9 million from income taxes, partly offset by $26 million from accounts payables and accrued expenses, and $8 million from receivables.

**Operating cash flow** increased by $81 million to $258 million compared to the prior year, mainly because of higher net income, more positive non-cash items and less unfavorable effects from changes in operating working capital, as outlined above.

**Capital expenditure, net** decreased by $40 million compared to the prior year. The level of capital expenditure, net, in relation to sales declined to 3.9% versus 5.7% a year earlier. The lower level of capital expenditure, net is mainly related to the lower activity level of footprint optimization in Europe and Americas and less capacity expansion, especially in Asia.

**Free operating cash flow** (Non-U.S. GAAP measure, see reconciliation table below) was positive $153 million compared to positive $32 million in the prior year. The increase was due to the higher operating cash flow and lower capital expenditure, net, as outlined above.

**Cash conversion** (Non-U.S. GAAP measure, see reconciliation table below) defined as free operating cash flow (Non-U.S. GAAP measure, see reconciliation table below) in relation to net income, was 87% in the quarter compared to 23% a year earlier. The increase occurred because free operating cash flow increased more than net income.

**Net debt** (Non-U.S. GAAP measure, see reconciliation table below) was $1,772 million as of September 30, 2025, which was $15 million lower than a year earlier, mainly due to that in the last twelve months, free operating cash flow was higher than dividends paid and share repurchases.

**Total equity** as of September 30, 2025, increased by $261 million compared to September 30, 2024. This was mainly due to net income of $754 million and $33 million in positive currency translation effects, partly offset by $306 million in share repurchases, including taxes and $228 million in dividend payments.

**Leverage ratio**: On September 30, 2025, the Company had a leverage ratio (Non-U.S. GAAP measure, see reconciliation table below) of 1.3x compared to 1.4x on September 30, 2024, as the 12 months trailing adjusted EBITDA (Non-U.S. GAAP measure, see reconciliation table below) increased by $148 million while net debt (Non-U.S. GAAP measure, see reconciliation table below) per the policy increased by $5 million.

### First nine months of 2025 development

**Operating cash flow** decreased by $27 million to $613 million compared to the prior year, mainly because the increase in operating working capital was larger than the increase in net income.

**Capital expenditure, net** decreased by $118 million compared to the prior year. The level of capital expenditure, net, in relation to sales declined to 3.9% versus 5.5% a year earlier. The lower level of capital expenditure, net is mainly related to the lower activity level of footprint optimization in Europe and Americas and less capacity expansion, especially in Asia.

**Free operating cash flow** (Non-U.S. GAAP measure, see reconciliation table below) was positive $300 million compared to positive $208 million in the prior year. The increase was due to the lower capital expenditure, net, partly offset by the lower operating cash flow, as outlined above.

**Cash conversion** (Non-U.S. GAAP measure, see reconciliation table below) defined as free operating cash flow (Non-U.S. GAAP measure, see reconciliation table below) in relation to net income, was 59% for the period, compared to 52% in the prior year. The increase occurred because free operating cash flow growth was higher than net income growth.

### COMMITMENTS

The Company has entered into a 5-year Enterprise Subscription Agreement (EAS). The subscription fees for the software licenses will be paid annually in advance. The future payments (undiscounted) relating to this software subscription agreement are in total approximately $50 million to be paid over the following years: Less than 1 year: $12 million; 1-3 years: $25 million; 3-5 years: $13 million.

### NON-U.S. GAAP MEASURES

The Company believes that comparability between periods is improved through the exclusion of certain items. To assist investors in understanding the operating performance of Autoliv's business, it is useful to consider certain U.S. GAAP measures exclusive of these items.

The following tables reconciles Income before income taxes, Net income attributable to controlling interest, Capital employed, which are inputs utilized to calculate Return On Capital Employed (“ROCE”), adjusted ROCE and Return On Total Equity (“ROE”). The Company believes this presentation may be useful to investors and industry analysts who utilize these adjusted non-U.S. GAAP measures in their ROCE and ROE calculations to exclude certain items for comparison purposes across periods. Autoliv’s management uses the ROCE, adjusted ROCE and ROE measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company’s business.

As used by the Company, ROCE is annualized operating income and income from equity method investments, relative to average capital employed. Adjusted ROCE is annualized operating income and income from equity method investments, relative to average capital employed as adjusted to exclude certain non-recurring items. See definitions of "annualized operating income" and "average capital employed" in footnote to the tables below. The Company believes ROCE and adjusted ROCE are useful indicators of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company’s capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. See definitions of "annualized income" "and "average total equity" in footnote to the tables below. The Company’s management believes that ROE is a useful indicator of how well management creates value for its shareholders through its operating activities and its capital management.

Accordingly, the tables below reconcile from U.S. GAAP to the equivalent non-U.S. GAAP measure.

### Reconciliation of GAAP measure "Operating income" to Non-GAAP measure "Adjusted Operating income"

*(Dollars in millions)*

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Operating income (GAAP)** | **$267** | **$226** | **$769** | **$626** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 2 | 9 | 6 | 25 |
| Less: Antitrust related items | 2 | 2 | 3 | 6 |
| **Total non-GAAP adjustments to operating income** | **4** | **11** | **8** | **31** |
| **Adjusted Operating income (Non-GAAP)** | **$271** | **$237** | **$777** | **$657** |

### Reconciliation of GAAP measure "Operating margin" to Non-GAAP measure "Adjusted Operating margin"

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Operating margin (GAAP)** | **9.9%** | **8.9%** | **9.6%** | **8.1%** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 0.1% | 0.4% | 0.1% | 0.3% |
| Less: Antitrust related items | 0.1% | 0.1% | 0.0% | 0.1% |
| **Total non-GAAP adjustments to operating margin** | **0.1%** | **0.4%** | **0.1%** | **0.4%** |
| **Adjusted Operating margin (Non-GAAP)** | **10.0%** | **9.3%** | **9.7%** | **8.5%** |

29

### Reconciliation of GAAP measure "Income before income taxes" to Non-GAAP measure "Adjusted Income before income taxes"

*(Dollars in millions)*

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Income before income taxes (GAAP)** | **$240** | **$197** | **$693** | **$554** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 2 | 9 | 6 | 25 |
| Less: Antitrust related items | 2 | 2 | 3 | 6 |
| **Total non-GAAP adjustments to Income before income taxes** | **4** | **11** | **8** | **31** |
| **Adjusted Income before income taxes (Non-GAAP)** | **$244** | **$208** | **$702** | **$585** |

### Reconciliation of GAAP measure "Net income" to Non-GAAP measure "Adjusted Net income"

*(Dollars in millions)*

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Net income (GAAP)** | **$175** | **$139** | **$510** | **$404** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 2 | 9 | 6 | 25 |
| Less: Antitrust related items | 2 | 2 | 3 | 6 |
| Less: Tax on non-GAAP adjustments | (1) | (3) | (2) | (5) |
| **Total non-GAAP adjustments to Net income** | **3** | **8** | **7** | **26** |
| **Adjusted Net income (Non-GAAP)** | **$178** | **$147** | **$517** | **$430** |

**Reconciliation of GAAP measure "Net income attributable to controlling interest" to Non-GAAP measure "Adjusted Net income attributable to controlling interest"**

*(Dollars in millions)*

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to controlling interest (GAAP)** | **$175** | **$138** | **$509** | **$403** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 2 | 9 | 6 | 25 |
| Less: Antitrust related items | 2 | 2 | 3 | 6 |
| Less: Tax on non-GAAP adjustments | (1) | (3) | (2) | (5) |
| **Total non-GAAP adjustments to Net income attributable to controlling interest** | **3** | **8** | **7** | **26** |
| **Adjusted Net income attributable to controlling interest (Non-GAAP)** | **$178** | **$146** | **$516** | **$429** |

### Reconciliation of GAAP measure "Earnings per share - diluted" to Non-GAAP measure "Adjusted Earnings per share - diluted"

| (Per share data) | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Earnings per share - diluted (GAAP)** | **$2.28** | **$1.74** | **$6.59** | **$4.98** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 0.03 | 0.12 | 0.07 | 0.31 |
| Less: Antitrust related items | 0.02 | 0.02 | 0.04 | 0.07 |
| Less: Tax on non-GAAP adjustments | (0.01) | (0.04) | (0.02) | (0.06) |
| **Total non-GAAP adjustments to Earnings per share - diluted** | **0.04** | **0.10** | **0.09** | **0.32** |
| **Adjusted Earnings per share - diluted (Non-GAAP)** | **$2.32** | **$1.84** | **$6.67** | **$5.30** |
| Weighted average number of shares outstanding - diluted | 76.7 | 79.3 | 77.3 | 80.9 |

30

### Reconciliation of GAAP measure "Return on Capital Employed" to Non-GAAP measure "Adjusted Return on Capital Employed"

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| Return on capital employed1) (GAAP) | **25.1%** | **22.9%** | **24.9%** | **21.2%** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 0.2% | 0.8% | 0.2% | 0.8% |
| Less: Antitrust related items | 0.1% | 0.2% | 0.1% | 0.2% |
| Total non-GAAP adjustments to Return on capital employed1) | **0.3%** | **1.0%** | **0.3%** | **1.0%** |
| Adjusted Return on capital employed1) (Non-GAAP) | **25.5%** | **23.9%** | **25.2%** | **22.1%** |
| Annualized adjustment2) on Return on capital employed1) | $15 | $44 | 11 | 42 |
| 1) Annualized operating income and income from equity method investments, relative to average capital employed. The average capital employed amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. |  |  |  |  |
| 2) The quarterly annualized adjustment to the operating income and income from equity method investments amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the operating income and income from equity method investments amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. |  |  |  |  |

### Reconciliation of GAAP measure "Return on Total Equity" to Non-GAAP measure "Adjusted Return on Total Equity"

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| Return on total equity1) (GAAP) | **27.9%** | **24.1%** | **28.1%** | **22.4%** |
| Non-GAAP adjustments: |  |  |  |  |
| Less: Capacity alignments | 0.3% | 1.4% | 0.3% | 1.3% |
| Less: Antitrust related items | 0.2% | 0.3% | 0.1% | 0.3% |
| Less: Tax on non-GAAP adjustments | (0.1)% | (0.5)% | (0.1)% | (0.3)% |
| Total non-GAAP adjustments to Return on total equity1) | **0.4%** | **1.2%** | **0.3%** | **1.3%** |
| Adjusted Return on total equity1) (Non-GAAP) | **28.3%** | **25.3%** | **28.4%** | **23.7%** |
| Annualized adjustment2) on Return on total equity1) | $12 | $32 | 9 | 35 |
| 1) Annualized net income relative to average total equity. The average total equity amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. |  |  |  |  |
| 2) The quarterly annualized adjustment to net income amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the net income amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. |  |  |  |  |

Autoliv from time to time enters into “debt-related derivatives” (DRDs) as a part of its debt management and as part of efficiently managing the Company’s overall cost of funds. Creditors and credit rating agencies use net debt adjusted for DRDs in their analyses of the Company’s debt, therefore we provide this non-U.S. GAAP measure. DRDs are fair value adjustments to the carrying value of the underlying debt. Also included in the DRDs is the unamortized fair value adjustment related to a discontinued fair value hedge that will be amortized over the remaining life of the debt. By adjusting for DRDs, the total financial liability of net debt is disclosed without grossing debt up with currency or interest fair values.

### Reconciliation of U.S. GAAP financial measure to “Net debt”

### (Dollars in millions)

|  | September 30, 2025 | June 30, 2025 | September 30, 2024 |
| --- | ---: | ---: | ---: |
| Short-term debt | $654 | $679 | $624 |
| Long-term debt | 1,374 | 1,372 | 1,586 |
| **Total debt** | **2,027** | **2,051** | **2,210** |
| Cash and cash equivalents | (225) | (237) | (415) |
| Debt issuance cost/Debt-related derivatives, net | (30) | (62) | (9) |
| **Net debt** | **$1,772** | **$1,752** | **$1,787** |

31

The non-U.S. GAAP measure “Net debt” is also used in the non-U.S. GAAP measure “Leverage ratio”. Management uses the non-U.S. GAAP measure “Leverage Ratio” to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. The Company's long-term target for the leverage ratio (sum of net debt plus pension liabilities divided by EBITDA) is 1.0x with the aim to operate within the range of 0.5x to 1.5x. For details and calculation of leverage ratio, refer to the table below.

### Calculation of “Leverage ratio”

### (Dollars in millions)

*(Dollars in millions)*

|  | September 30, 2025 | June 30, 2025 | September 30, 2024 |
| --- | ---: | ---: | ---: |
| Net debt1) | $1,772 | $1,752 | $1,787 |
| Pension liabilities | 167 | 167 | 147 |
| **Net debt per the Policy** | **1,939** | **1,919** | **1,934** |
| Net income2) | 754 | 717 | 632 |
| Income taxes 2) | 261 | 255 | 141 |
| Interest expense, net2,3) | 94 | 96 | 93 |
| Other non-operating items, net2) | 20 | 19 | 4 |
| Income from equity method investments2) | (6) | (6) | (6) |
| Depreciation and amortization of intangibles2) | 397 | 390 | 385 |
| Capacity alignments2) | (1) | 6 | 121 |
| Antitrust related items2) | 5 | 6 | 7 |
| Other items2) | — | — | 0 |
| **EBITDA per the Policy (Adjusted EBITDA)** | **$1,524** | **$1,483** | **$1,376** |
| **Leverage ratio** | **1.3** | **1.3** | **1.4** |

1\) Net debt (non-U.S. GAAP measure) is short- and long-term debt and debt-related derivatives, less cash and cash equivalents.

2\) Latest 12-months.

3\) Interest expense, net including cost for extinguishment of debt, if any, less interest income.

Management uses the non-U.S. GAAP measure “free operating cash flow” to analyze the amount of cash flow being generated by the Company’s operations after capital expenditure, net. This measure indicates the Company’s cash flow generation level that enables strategic value creation options such as dividends or acquisitions. For details on the calculation of free operating cash flow, see the table below. Management uses the non-U.S. GAAP measure “cash conversion” to analyze the proportion of net income that is converted into free operating cash flow. The measure is a tool to evaluate how efficiently the Company utilizes its resources. For details on cash conversion, see the table below.

### Reconciliation of GAAP measure "Operating cash flow" to "Free operating cash flow" and "Cash conversion"

### (Dollars in millions)

|  | Three Months Ended September 30, 2025 | 2024 | Nine Months Ended September 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| **Net income** | **$175** | **$139** | **$510** | **$404** |
| Changes in operating working capital | (53) | (68) | (217) | (54) |
| Depreciation and amortization | 103 | 97 | 299 | 289 |
| Gain on divestiture of property | 0 | — | (6) | — |
| Other, net | 32 | 10 | 26 | 1 |
| **Operating cash flow** | **258** | **177** | **613** | **639** |
| Expenditures for property, plant and equipment | (106) | (146) | (323) | (440) |
| Proceeds from sale of property, plant and equipment | 1 | 1 | 10 | 9 |
| **Capital expenditure, net1)** | **(106)** | **(145)** | **(313)** | **(431)** |
| Free operating cash flow2) | **$153** | **$32** | **$300** | **$208** |
| Cash conversion3) | 87% | 23% | 59% | 52% |
| 1) Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. |  |  |  |  |
| 2) Operating cash flow less Capital expenditures, net. |  |  |  |  |
| 3) Free operating cash flow relative to Net income. |  |  |  |  |

32

### Headcount

|  | September 30, 2025 | June 30, 2025 | September 30, 2024 |
| --- | ---: | ---: | ---: |
| Total headcount | 65,200 | 65,100 | 67,200 |
| Whereof: |  |  |  |
| Direct personnel in manufacturing | 47,900 | 48,000 | 49,800 |
| Indirect personnel | 17,300 | 17,100 | 17,400 |
| Temporary personnel | 9% | 9% | 9% |

As of September 30, 2025, total headcount Full Time Equivalent (FTE) decreased by around 2,000, or 3.0%, compared to a year earlier, despite that organic sales (Non-U.S. GAAP measure, see reconciliation table above) increased by 3.9% and that we in-sourced about 250 FTEs (mainly indirects). The indirect workforce decreased by around 100, or 0.5%, mainly reflecting our structural reduction initiatives, partly offset by the above mentioned in-sourcing. The direct workforce decreased by approximately 1,900, or 3.8%. The decrease was supported by an improvement in customer call-off accuracy which enabled us to accelerate operating efficiency improvements.

Compared to June 30, 2025, total headcount (FTE) increased by around 100, or 0.2%. Indirect headcount increased by around 200 (due to the in-sourced personnel mentioned previously), while direct headcount decreased by approximately 100.

### Full year 2025 guidance

In addition to the assumptions and our business and market update noted below, our full year 2025 guidance is based on our customer call-offs, as well as the achievement of our targeted cost compensation adjustments with our customers, including for the new tariffs, no further material changes to tariffs or trade restrictions, as compared to what is in effect as of October 15, 2025, as well as no significant changes in the macro-economic environment, changes to customer call-off volatility or significant supply chain disruptions.

| Full year 2025 Guidance |  |
| --- | --- |
| Organic sales growth | Around 3% |
| Adjusted operating margin 1) | Around 10-10.5% |
| Operating cash flow 2) | Around $1.2 billion |
| Capital expenditures, net % of sales | Around 4.5% |
| 1) Excluding effects from capacity alignments, antitrust related matters and other discrete items. |  |
| 2) Excluding unusual items. |  |
| **Full year 2025 Assumptions** |  |
| LVP growth | Around 1.5% |
| Foreign currency impact on net sales | Around 1% |
| Tax rate3) | Around 28% |
| 3) Excluding unusual tax items. |  |

This report includes content supplied by S&P Global; Copyright © Light Vehicle Production Forecast, January, March, July and October 2025. All rights reserved.

The forward-looking non-U.S. GAAP financial measures above are provided on a non-U.S. GAAP basis. The Company has not provided a U.S. GAAP reconciliation of these measures because items that impact these measures, such as costs and gains related to capacity alignments and antitrust matters, cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and the Company is unable to determine the probable significance of the unavailable information.

### Other recent events

### Key launches in the three months period ended September 30, 2025

- **Onvo L90**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Steering Wheel, Front Center Airbag, Seatbelts.
- **Kia PV5**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Front Center Airbag.
- **New EV Customer SUV**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Front Center Airbag, Seatbelts.
- **Volvo XC70**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Steering Wheel, Front Center Airbag, Seatbelts.
- **New EV Customer SUV**: Driver/Passenger Airbags, Side Airbags, Steering Wheel.
- **Subaru Outback**: Driver/Passenger Airbags, Side Airbags, Seatbelts.
- **Jeep Compass**: Driver/Passenger Airbags, Steering Wheel.
- **Renault Clio**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Steering Wheel, Seatbelts.
- **Geely Galaxy M9**: Driver/Passenger Airbags, Side Airbags, Head/Inflatable Curtain Airbags, Front Center Airbag, Seatbelts.
- **Nissan Sentra**: Side Airbags, Head/Inflatable Curtain Airbags, Seatbelts.
- **New EV**: Side Airbags, Steering Wheel, Seatbelts.
- **Honda N-ONE e**: Driver/Passenger Airbags, Side Airbags, Seatbelts.

### Other Items

- On October 14, 2025, Autoliv announced the signing of a strategic agreement with China Automotive Technology and Research Center Co (CATARC), the leading research institution setting standards in China’s automotive sector, to jointly advance automotive safety standards and innovation in China and beyond. The collaboration will span research and development, testing, certification, and standards alignment - providing technical support for the R&D and global expansion of Chinese automakers.
- On October 9, 2025, Autoliv announced its intent to form a new joint venture with Hangsheng Electric Co., Ltd. (HSAE), a leading Chinese developer of automotive electronics. The joint venture will focus on developing and manufacturing advanced safety electronics for the rapidly evolving Chinese automotive market. The new joint venture will be located strategically near Shanghai and close to several existing Autoliv sites in China. The focus will be on products that include features such as Hands-On Detection (HOD), Pre-Pretensioner Mechatronic Integration (PPMI) and electronic applications for seatbelt systems and driver units.
- On July 27, 2025, Autoliv China officially held the groundbreaking ceremony for its new R&D center in Wuhan, China. This initiative reflects Autoliv’s long-term commitment to the Chinese market and supports the global growth of Chinese OEMs. The center is scheduled to begin operations in Q3 2026 and will be equipped with state-of-the-art testing equipment and a digital R&D platform. It will play a critical role in advancing automotive safety technologies and enhancing Autoliv’s capabilities in delivering secure and reliable innovative mobility solutions to customers worldwide.
- In Q3 2025, Autoliv repurchased and retired 0.84 million shares of common stock at an average price of $118.75 per share under the Autoliv 2029 stock repurchase program. Under this program, repurchases may be made from July 1, 2025 through December 31, 2029. The maximum value of aggregate repurchases under this program is $2.5 billion. Repurchases of stock may be made directly on the NYSE or indirectly through the repurchase of SDRs traded on the Stockholm Nasdaq.

## Market risk

As filed, 291 characters.

As of September 30, 2025, there have been no material changes to the information related to quantitative and qualitative disclosures about market risk that were provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 20, 2025.

## Controls and procedures

As filed, 1,140 characters.

(a) Evaluation of Disclosure Controls and Procedures

An evaluation has been carried out, under the supervision and with the participation of the Company's management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures are effective.

(b) Changes in Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 6,503 characters.

Except for below, as of September 30, 2025, there have been no material changes to the risk factors that were previously disclosed in Item 1A in the Company’s Form 10-K for the year ended December 31, 2024 filed with the SEC on February 20, 2025.

### RISKS RELATED TO INTERNATIONAL OPERATIONS

### Our business is exposed to risks inherent in international operations

We currently conduct operations in various countries and jurisdictions, including locating certain of our manufacturing and distribution facilities internationally, which subjects us to the legal, political, regulatory and social requirements and economic conditions in these jurisdictions. Some of these countries are considered growth markets and emerging markets. International sales and operations, especially in growth markets, subject us to certain risks inherent in doing business abroad, including: exposure to local economic conditions; unexpected changes in laws, regulations, trade, or monetary or fiscal policy, including interest rates, foreign currency exchange rates, and changes in inflation rates; foreign tax consequences; inability to collect, or delays in collecting, value-added taxes and/or other receivables associated with remittances and other payments by subsidiaries; exposure to local political turmoil and challenging labor conditions; changes in general economic and political conditions in countries where we operate, particularly in emerging markets; expropriation and nationalization; enforcing legal agreements or collecting receivables through foreign legal systems; wage inflation; currency controls, including lack of liquidity in foreign currency due to governmental restrictions, trade protection policies and currency controls, which may create difficulty in repatriating profits or making other remittances; compliance with the requirements of an increasing body of applicable anti-bribery laws; reduced intellectual property protection in various markets; investment restrictions or requirements; and the imposition of product tariffs and the burden of complying with a wide variety of international and U.S. export laws. The Company is subject to taxation in the U.S. and numerous foreign jurisdictions. The Organization for Economic Co-operation and Development (“OECD”) continues its base erosion and profit shifting (“BEPS”) project begun in 2015 with new proposals for a global minimum tax, further development of a coordinated set of rules for taxation and the allocation of taxing rights between jurisdictions. These proposals, if adopted by countries in which we operate, could result in changes to tax policies, including transfer pricing policies, which could ultimately impact our tax liabilities.

Changes in tax laws or policies by the U.S. or foreign jurisdictions could result in a higher effective tax rate on our worldwide earnings, and any such change could have a material adverse effect on our business prospects, cash flows, operating results and financial condition.

Our international operations also depend upon favorable trade relations between the countries where we manufacture and sell products and those foreign countries in which our customers and suppliers have operations. The current U.S. presidential administration has created uncertainty about the future relationship between the U.S. and its trading partners, including with respect to the trade policies and agreements, treaties, government regulations and tariffs that could apply to trade between the U.S. and other nations. In recent months, the U.S. has announced substantial increases in tariffs on imports from China, and China has responded with expanded export restrictions on critical minerals and technologies, as well as retaliatory measures affecting U.S. goods and services. These developments reflect a broader trend of escalating trade tensions and policy volatility between the two countries. Changes in national policy, other governmental action related to tariffs or international trade agreements, changes in social, political, regulatory, and economic conditions or in laws and policies governing foreign trade, manufacturing, development and investment in the territories and countries where the Company currently manufactures and sells products, and any resulting negative sentiments towards the Company as a result of such changes could depress economic activity and restrict our access to suppliers or customers and have a material adverse effect on our cash flows, operating results and financial condition.

Increasing our manufacturing footprint in the growth markets and our business relationships with automotive manufacturers in these markets are particularly important elements of our strategy. As a result, our exposure to the risks described above may be greater in the future, and our exposure to risks associated with developing countries, such as the risk of political upheaval and reliability of local infrastructure, may increase. It could also impact importing certain foreign-produced vehicles into the U.S. Changes in national policy or continued uncertainty could depress economic activity and restrict our access to suppliers or customers and have a material adverse effect on our cash flows, operating results and financial condition. Additionally, such trade restrictions or material increases in tariffs could impact our targets, earnings guidance, and estimates. The ultimate impact of any tariffs, including any related responses, are uncertain and will depend on various factors, including if any tariffs are ultimately implemented, the timing of implementation, and the amount, scope, and nature of the tariffs. Any or all of these actions could adversely affect our business, financial condition and cash flows. Increasing our manufacturing footprint in the growth markets and our business relationships with automotive manufacturers in these markets are particularly important elements of our strategy. As a result, our exposure to the risks described above may be greater in the future, and our exposure to risks associated with developing countries, such as the risk of political upheaval and reliability of local infrastructure, may increase. It could also impact importing certain foreign-produced vehicles into the U.S. Changes in national policy or continued uncertainty could depress economic activity and restrict our access to suppliers or customers and have a material adverse effect on our cash flows, operating results and financial condition.

Filed Oct 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-242063. Last ingested by Listed: Nov 14, 2026, 11:22 ET. No prices; not investment advice.
